These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2210330)

  • 1. Separation of plasmid-mediated extended spectrum beta-lactamases by fast protein liquid chromatography (FPLC system).
    Payne DJ; Hood J; Marriott MS; Amyes SG
    FEMS Microbiol Lett; 1990 Jun; 57(3):195-200. PubMed ID: 2210330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
    Payne DJ; Marriott MS; Amyes SG
    J Med Microbiol; 1990 Jun; 32(2):131-4. PubMed ID: 2192063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate.
    Bradford PA; Cherubin CE; Idemyor V; Rasmussen BA; Bush K
    Antimicrob Agents Chemother; 1994 Apr; 38(4):761-6. PubMed ID: 8031043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SHV-27, a novel cefotaxime-hydrolysing beta-lactamase, identified in Klebsiella pneumoniae isolates from a Brazilian hospital.
    Corkill JE; Cuevas LE; Gurgel RQ; Greensill J; Hart CA
    J Antimicrob Chemother; 2001 Apr; 47(4):463-5. PubMed ID: 11266422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First identification of an SHV-12 extended-spectrum beta-lactamase in Klebsiella pneumoniae isolated in Italy.
    Laksai Y; Severino M; Perilli M; Amicosante G; Bonfiglio G; Stefani S
    J Antimicrob Chemother; 2000 Mar; 45(3):349-51. PubMed ID: 10702555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of five plasmid-mediated ceftazidimases isolated in Klebsiella pneumoniae.
    Sirot D; Chanal C; Labia R; Meyran M; Sirot J; Cluzel R
    J Antimicrob Chemother; 1989 Oct; 24(4):509-21. PubMed ID: 2693430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins.
    Petit A; Sirot DL; Chanal CM; Sirot JL; Labia R; Gerbaud G; Cluzel RA
    Antimicrob Agents Chemother; 1988 May; 32(5):626-30. PubMed ID: 3293523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TEM-71, a novel plasmid-encoded, extended-spectrum beta-lactamase produced by a clinical isolate of Klebsiella pneumoniae.
    Rasheed JK; Anderson GJ; Queenan AM; Biddle JW; Oliver A; Jacoby GA; Bush K; Tenover FC
    Antimicrob Agents Chemother; 2002 Jun; 46(6):2000-3. PubMed ID: 12019125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of a novel plasmid-mediated beta-lactamase, CAZ-2, and the CTX-1 and CAZ-1 enzymes conferring resistance to broad-spectrum cephalosporins.
    Chanal CM; Sirot DL; Labia R; Petit A; Morand A; Sirot JL; Cluzel RA
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1660-5. PubMed ID: 3075436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel transferable extended-spectrum beta-lactamase (SHV-6) from Klebsiella pneumoniae conferring selective resistance to ceftazidime.
    Arlet G; Rouveau M; Bengoufa D; Nicolas MH; Philippon A
    FEMS Microbiol Lett; 1991 Jun; 65(1):57-62. PubMed ID: 1874404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.
    Stürenburg E; Kühn A; Mack D; Laufs R
    J Antimicrob Chemother; 2004 Aug; 54(2):406-9. PubMed ID: 15201232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transferable resistance to cefotaxime in nosocomial Klebsiella pneumoniae and Escherichia coli strains due to their production of extended-spectrum beta-lactamase in Slovakia.
    Hupková M; Blahová J; Babálová M; Krcméry V; Králiková K
    J Chemother; 1995 Feb; 7(1):16-20. PubMed ID: 7629551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.
    Quinn JP; Miyashiro D; Sahm D; Flamm R; Bush K
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1451-6. PubMed ID: 2684007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-level resistance to cefotaxime and ceftazidime in Klebsiella pneumoniae isolates from Cleveland, Ohio.
    Thomson KS; Sanders CC; Washington JA
    Antimicrob Agents Chemother; 1991 May; 35(5):1001-3. PubMed ID: 1854155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmid-mediated beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime.
    Vuye A; Verschraegen G; Claeys G
    Antimicrob Agents Chemother; 1989 May; 33(5):757-61. PubMed ID: 2665644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of a transferable SHV-5 type beta-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece.
    Vatopoulos AC; Philippon A; Tzouvelekis LS; Komninou Z; Legakis NJ
    J Antimicrob Chemother; 1990 Nov; 26(5):635-48. PubMed ID: 2079446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of TEM-10 beta-lactamases encoded by different nucleotide sequences.
    Rasmussen BA; Bradford PA; Quinn JP; Wiener J; Weinstein RA; Bush K
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1989-92. PubMed ID: 8239618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of a new plasmid-encoded SHV-type beta-lactamase (SHV-2 variant) conferring high-level cefotaxime resistance upon Klebsiella pneumoniae.
    Podbielski A; Schönling J; Melzer B; Warnatz K; Leusch HG
    J Gen Microbiol; 1991 Mar; 137(3):569-78. PubMed ID: 2033379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLA-1: a new plasmid-mediated extended-spectrum beta-lactamase from Escherichia coli.
    Silva J; Aguilar C; Ayala G; Estrada MA; Garza-Ramos U; Lara-Lemus R; Ledezma L
    Antimicrob Agents Chemother; 2000 Apr; 44(4):997-1003. PubMed ID: 10722503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan.
    Wachino J; Doi Y; Yamane K; Shibata N; Yagi T; Kubota T; Ito H; Arakawa Y
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1960-7. PubMed ID: 15155185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.